| Name | Title | Contact Details |
|---|
Our vision is a world where genomic information is fully accessible, understandable and integrated into health and well being. We are on a mission to help patients and healthcare providers use genetic services to improve health, lower the cost of care, and prevent disease.
Neurology Partners is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Envision Healthcare is on the front lines of change. Through our primary business units – Envision Physician Services, Evolution Health and AMSURG – our clinician-led organization is changing the face of healthcare by delivering high-quality care that elevates the patient experience. Envision Healthcare is pioneering solutions to the toughest challenges in healthcare. We serve as a partner to help navigate the constantly evolving landscape of healthcare delivery, and we are vigilant in working with health systems and hospitals to identify opportunities to better serve our communities. Our physicians, advanced practice providers and support teams are responsible for more than 30 million annual patient encounters across the U.S. Learn more about how we care for patients here.MISSION Our mission is to improve the patient experience and public health while reducing the cost of available healthcare per capita. As the largest provider of physician services to hospital and health systems through Envision Physician Services, we are committed to supporting our hospital and health system partners in delivering local, high-quality care. COMMUNITIES Our employees are committed to supporting the communities we serve by providing charitable donations. Our time is dedicated to helping our communities remain safe, active, healthy and productive by getting involved and giving back.
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Pride Mobility Products® Corporation is the worlds leading designer and manufacturer of mobility products including Jazzy® Power Chairs, Go-Go® Travel Mobility, Pride® Mobility Scooters, Pride® Power Lift Recliners, and Pride® Lifts and Ramps. The Pride family of companies also includes Quantum Rehab®, a leader in complex rehab power chairs with the Q6 Edge® 2.0, 4Front™, and Q6 Series of power bases, TRU-Balance® 3 Power Positioning Systems, and Q-Logic 3 Advanced Drive Controls, as well as Stealth Products®, the foremost manufacturer of positioning components. Headquartered in Exeter, Pennsylvania, Pride also has operations in Australia, Canada, China, Italy, the Netherlands, New Zealand, and the United Kingdom. Pride is dedicated to providing expertly designed, engineered, and tested products incorporating technologically innovative features enabling consumers to achieve the highest quality of life and mobility goals. Pride helps millions of people live their lives to the fullest by creating the best personal mobility products in the world. Pride’s products serve the widest range of mobility needs, with a family of brands that are industry leaders in changing lives. Our employees are treated with respect and provided with an equal opportunity to contribute to the success of our company and their own personal growth. Pride Mobility Products Corporation is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected Veteran status.